Amgen Inc
NASDAQ:AMGN
Amgen Inc
Other Non-Cash Items
Amgen Inc
Other Non-Cash Items Peer Comparison
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$1.8B
|
CAGR 3-Years
157%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$7.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
29%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$8.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
35%
|
CAGR 10-Years
37%
|
|
Moderna Inc
NASDAQ:MRNA
|
Other Non-Cash Items
$296m
|
CAGR 3-Years
18%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$585.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
110%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Amgen Inc's Other Non-Cash Items?
Other Non-Cash Items
1.8B
USD
Based on the financial report for Mar 31, 2024, Amgen Inc's Other Non-Cash Items amounts to 1.8B USD.
What is Amgen Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
13%
The average annual Other Non-Cash Items growth rates for Amgen Inc have been 157% over the past three years , 24% over the past five years , and 13% over the past ten years .